Combination of leading nanopore sequencing technology with cloud-based SAAS analysis platform will help microbiologists gain critical infectious disease insights from genomic data OXFORD, UK — Oxford Nanopore Technologies (Oxford Nanopore) the company behind a new generation of molecular sensing technology based on nanopores, and BugSeq, a leading provider of fully automated infectious disease bioinformatics services, […]
PanOmiQ completes Whole Genome Sequencing analysis with a clinical report in 7 hours. CALGARY, AB – BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human genome. With unparalleled speed, precision, and […]
EchoLUTION Tissue RNA Kit is suitable for the extraction of a variety of tissues. Simple and fast extraction with a highly pure RNA outcome. Sustainable option eliminating the need to use phenol/chloroform . BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, has launched its latest product: the EchoLUTION Tissue RNA […]
New protocol for use in infectious disease research part of packed activity lineup for ESCMID Global 2024 OXFORD, UK — Oxford Nanopore Technologies (Oxford Nanopore), the company behind a new generation of molecular sensing technology based on nanopores, today announced its lineup of speakers and conference activities for the upcoming annual meeting of the European […]
Oxford, UK – Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products, ensuring seamless use in combination with Oxford Nanopore’s sequencing products. The programme will expand the network of products compatible with Oxford Nanopore’s platform to enhance the overall […]
German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biopharmaceutical product development Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025 DARMSTADT, GERMANY — Merck, a leading science and technology company, is investing more than € 300 million in a new research […]
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency […]
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform Substantially lowers hands-on time, allowing for increased lab productivity WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is […]
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples Panel significantly accelerates TB outbreak tracking and supports detection and management of antimicrobial resistance, critical needs in TB surveillance and control Building upon success of leading diagnostics test QuantiFERON-TB Gold Plus as QIAGEN extends portfolio for TB […]
SINGAPORE — GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into GenScript’s state-of-the-art gene and protein production facility, particularly highlighting the company’s advancements in AI-driven gene […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
